The Association of Waist Circumference and the Risk of Deep Vein Thrombosis

References

• Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320(15):1583–1594. doi:10.1001/jama.2018.14346
   PubMed Web of Science ®Google Scholar
• Kruger PC, Eikelboom JW, Douketis JD, et al. Deep vein thrombosis: update on diagnosis and management. Med J Aust. 2019;210(11):516–524. doi:10.5694/mja2.50201
   PubMed Web of Science ®Google Scholar
• Kearon C, de Wit K, Parpia S, et al. Diagnosis of pulmonary embolism with d-dimer adjusted to clinical probability. N Engl J Med. 2019;381(22):2125–2134. doi:10.1056/NEJMoa1909159
   PubMed Web of Science ®Google Scholar
• Wang T, Chen R, Liu C, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020;7(5):e362–e363. doi:10.1016/S2352-3026(20)30109-5
   PubMed Web of Science ®Google Scholar
• Gregson J, Kaptoge S, Bolton T, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol. 2019;4(2):163–173. doi:10.1001/jamacardio.2018.4537
   PubMed Web of Science ®Google Scholar
• Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–e440. doi:10.1016/S2352-3026(20)30145-9
   PubMed Web of Science ®Google Scholar
• Klarin D, Emdin CA, Natarajan P, et al. Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ Cardiovasc Genet. 2017;10(2):e001643. doi:10.1161/CIRCGENETICS.116.001643
   PubMedGoogle Scholar
• Horvei LD, Brækkan SK, Mathiesen EB, et al. Obesity measures and risk of venous thromboembolism and myocardial infarction. Eur J Epidemiol. 2014;29(11):821–830. doi:10.1007/s10654-014-9950-z
   PubMed Web of Science ®Google Scholar
• Glise Sandblad K, Jern S, Åberg M, et al. Obesity in adolescent men increases the risk of venous thromboembolism in adult life. J Intern Med. 2020;287(6):734–745. doi:10.1111/joim.13044
   PubMed Web of Science ®Google Scholar
• Yuan S, Bruzelius M, Xiong Y, et al. Overall and abdominal obesity in relation to venous thromboembolism. J Thromb Haemost. 2021;19(2):460–469. doi:10.1111/jth.15168
   PubMed Web of Science ®Google Scholar
• Matos MF, Lourenço DM, Orikaza CM, et al. Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6. Metab Syndr Relat Disord. 2013;11(1):29–34. doi:10.1089/met.2012.0077
   PubMed Web of Science ®Google Scholar
• Thuesen ACB, Vaag A. Perspectives on diabetes mortality as the result of residual confounding and reverse causality by common disease. Diabetes Obes Metab. 2018;20(6):1342–1349. doi:10.1111/dom.13238
   PubMed Web of Science ®Google Scholar
• Goldstein CE, Weijer C, Brehaut JC, et al. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation. BMC Med Ethics. 2018;19(1):1–10. doi:10.1186/s12910-018-0253-x
   PubMed Web of Science ®Google Scholar
• Chen Q, Li L, Yi J, et al. Waist circumference increases risk of coronary heart disease: evidence from a Mendelian randomization study. Mol Genet Genomic Med. 2020;8(4):e1186. doi:10.1002/mgg3.1186
   PubMed Web of Science ®Google Scholar
• He Y, Zheng C, He MH, et al. The causal relationship between body mass index and the risk of osteoarthritis. Int J Gen Med. 2021;14:2227. doi:10.2147/IJGM.S314180
   PubMed Web of Science ®Google Scholar
• Lamina C, Kronenberg F. Estimation of the required lipoprotein (a)-lowering therapeutic effect size for reduction in coronary heart disease outcomes: a Mendelian randomization analysis. JAMA Cardiol. 2019;4(6):575–579. doi:10.2147/IJGM.S314180
   PubMed Web of Science ®Google Scholar
• Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178:1177–1184. doi:10.1093/aje/kwt084
   PubMed Web of Science ®Google Scholar
• Hemani G, Zheng J, Elsworth B, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. doi:10.7554/eLife.34408
   PubMed Web of Science ®Google Scholar
• Marín-Martínez F, Sánchez-Meca J. Weighting by inverse variance or by sample size in random-effects meta-analysis. Educ Psychol Meas. 2010;70:56–73. doi:10.1177/0013164409344534
   Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Haycock PC, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–314. doi:10.1002/gepi.21965
   PubMed Web of Science ®Google Scholar
• Burgess S, Thompson SG; CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–764. doi:10.1093/ije/dyr036
   PubMed Web of Science ®Google Scholar
• Sloan M, Sheth N, Lee GC. Is obesity associated with increased risk of deep vein thrombosis or pulmonary embolism after hip and knee arthroplasty? A large database study. Clin Orthop Relat Res. 2019;477(3):523. doi:10.1097/CORR.0000000000000615
   PubMed Web of Science ®Google Scholar
• Vučković BA, Cannegieter SC, van Hylckama Vlieg A, et al. Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow‐up study. J Thromb Haemost. 2017;15(7):1430–1435. doi:10.1111/jth.13710
   PubMed Web of Science ®Google Scholar
• Tan JS, Liu NN, Guo TT, et al. Genetically predicted obesity and risk of deep vein thrombosis. Thromb Res. 2021;207:16–24. doi:10.1016/j.thromres.2021.08.026
   PubMed Web of Science ®Google Scholar
• Klovaite J, Benn M, Nordestgaard BG. Obesity as a causal risk factor for deep venous thrombosis: a M endelian randomization study. J Intern Med. 2015;277(5):573–584. doi:10.1111/joim.12299
   PubMed Web of Science ®Google Scholar
• Hansson PO, Eriksson H, Welin L, et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: the study of men born in 1913. Arch Intern Med. 1999;159(16):1886–1890. doi:10.1001/archinte.159.16.1886
   PubMed Web of Science ®Google Scholar
• Borch KH, Braekkan SK, Mathiesen EB, et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study. J Thromb Haemost. 2009;7(5):739–745. doi:10.1111/j.1538-7836.2008.03234.x
   PubMed Web of Science ®Google Scholar
• Li K, Feng T, Wang L, et al. Causal associations of waist circumference and waist-to-hip ratio with type II diabetes mellitus: new evidence from Mendelian randomization. Mol Genet Genomics. 2021;296(3):605–613. doi:10.1007/s00438-020-01752-z
   PubMed Web of Science ®Google Scholar
• Debette S, Wolf C, Lambert JC, et al. Abdominal obesity and lower gray matter volume: a Mendelian randomization study. Neurobiol Aging. 2014;35(2):378–386. doi:10.1016/j.neurobiolaging.2013.07.022
   PubMed Web of Science ®Google Scholar
• Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143(2):180–190. doi:10.1111/j.1365-2141.2008.07323.x
   PubMed Web of Science ®Google Scholar
• Shim YS, Kang MJ, Oh YJ, et al. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: the Korean National Health and Nutrition Examination Survey, 2008 to 2011. Medicine. 2017;96:8. doi:10.1097/MD.0000000000006179
   Web of Science ®Google Scholar
• Bouchouirab FZ, Fortin M, Noll C, et al. Plasma palmitoyl-carnitine (AC16: 0) is a marker of increased postprandial nonesterified incomplete fatty acid oxidation rate in adults with type 2 diabetes. Can J Diabetes. 2018;42(4):382–388. e1. doi:10.1016/j.jcjd.2017.09.002
   PubMed Web of Science ®Google Scholar
• Ghodoosi N, Mirzababaei A, Rashidbeygi E, et al. Associations of dietary inflammatory index, serum levels of MCP-1 and body composition in Iranian overweight and obese women: a cross-sectional study. BMC Res Notes. 2020;13(1):1–7. doi:10.1186/s13104-020-05390-x
   PubMed Web of Science ®Google Scholar
• Lteif A, Vaishnava P, Baron AD, et al. Endothelin limits insulin action in obese/insulin-resistant humans. Diabetes. 2007;56(3):728–734. doi:10.2337/db06-1406
   PubMed Web of Science ®Google Scholar
• Krüger N, Biwer LA, Good ME, et al. Loss of endothelial FTO antagonizes obesity-induced metabolic and vascular dysfunction. Circ Res. 2020;126(2):232–242. doi:10.1161/CIRCRESAHA.119.315531
   PubMed Web of Science ®Google Scholar
• Burgess S, Thompson S. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol. 2013;42:1134–1144. doi:10.1093/ije/dyt093
   PubMed Web of Science ®Google Scholar
• Tan JS, Yan XX, Wu Y, et al. Rare variants in MTHFR predispose to occurrence and recurrence of pulmonary embolism. Int J Cardiol. 2021;331:236–242. doi:10.1016/j.ijcard.2021.01.073
   PubMed Web of Science ®Google Scholar